| 28/06/22 | STX | 14:05:43 | 28 Jun 2022 | | STX | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 28/06/22 | STX | 14:00:42 | 28 Jun 2022 | | STX | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 29/04/22 | STX | 07:00:02 | 29 Apr 2022 | | STX | Total Voting Rights Update | Shield Therapeutics PLC | RNS |
| 31/03/22 | STX | 15:50:06 | 31 Mar 2022 | | STX | Block Listing Application | Shield Therapeutics PLC | RNS |
| 31/03/22 | STX | 15:50:06 | 31 Mar 2022 | | STX | Block Listing 6 Monthly Return | Shield Therapeutics PLC | RNS |
| 21/03/22 | STX | 07:00:08 | 21 Mar 2022 | | STX | KYE Pharmaceuticals Files Accrufer® NDS in Canada | Shield Therapeutics PLC | RNS |
| 25/02/22 | STX | 07:00:09 | 25 Feb 2022 | | STX | Investor Presentation | Shield Therapeutics PLC | RNS |
| 23/02/22 | STX | 14:06:15 | 23 Feb 2022 | | STX | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 23/02/22 | STX | 14:01:09 | 23 Feb 2022 | | STX | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 23/02/22 | STX | 11:05:51 | 23 Feb 2022 | | STX | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 23/02/22 | STX | 11:00:40 | 23 Feb 2022 | | STX | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 18/02/22 | STX | 14:06:01 | 18 Feb 2022 | | STX | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 18/02/22 | STX | 14:00:48 | 18 Feb 2022 | | STX | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 17/02/22 | STX | 09:05:58 | 17 Feb 2022 | | STX | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 17/02/22 | STX | 09:00:40 | 17 Feb 2022 | | STX | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 17/02/22 | STX | 07:00:08 | 17 Feb 2022 | | STX | Full Year Trading Update | Shield Therapeutics PLC | RNS |
| 04/02/22 | STX | 07:00:04 | 4 Feb 2022 | | STX | KOL Investor Event on Iron Deficiency | Shield Therapeutics PLC | RNS |
| 07/01/22 | STX | 07:00:07 | 7 Jan 2022 | | STX | Investor Presentation | Shield Therapeutics PLC | RNS |
| 05/01/22 | STX | 07:00:08 | 5 Jan 2022 | | STX | Licence Agreement in Canada for Accrufer® | Shield Therapeutics PLC | RNS |
| 30/12/21 | STX | 09:06:12 | 30 Dec 2021 | | STX | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 30/12/21 | STX | 09:00:55 | 30 Dec 2021 | | STX | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 29/12/21 | STX | 11:05:44 | 29 Dec 2021 | | STX | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 29/12/21 | STX | 11:00:40 | 29 Dec 2021 | | STX | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 16/12/21 | STX | 11:05:51 | 16 Dec 2021 | | STX | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 16/12/21 | STX | 11:00:49 | 16 Dec 2021 | | STX | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 16/12/21 | STX | 07:00:04 | 16 Dec 2021 | | STX | Patient Access Expands for Accrufer® | Shield Therapeutics PLC | RNS |
| 30/09/21 | STX | 17:30:05 | 30 Sept 2021 | | STX | Block Listing 6 Monthly Return | Shield Therapeutics PLC | RNS |
| 27/09/21 | STX | 07:00:07 | 27 Sept 2021 | | STX | Jose A. Menoyo Appointed as Chief Medical Officer | Shield Therapeutics PLC | RNS |
| 21/09/21 | STX | 07:00:11 | 21 Sept 2021 | | STX | Investor presentation | Shield Therapeutics PLC | RNS |
| 23/08/21 | STX | 07:00:05 | 23 Aug 2021 | | STX | PDMR Transaction Notification | Shield Therapeutics PLC | RNS |
| 17/08/21 | STX | 07:00:03 | 17 Aug 2021 | | STX | Half-year Report | Shield Therapeutics PLC | RNS |
| 12/08/21 | | 07:00:07 | 12 Aug 2021 | | | Licence agreement secured in Republic of Korea | Shield Therapeutics PLC | RNS |
| 11/08/21 | | 07:00:12 | 11 Aug 2021 | | | Notice of Results | Shield Therapeutics PLC | RNS |
| 09/08/21 | | 07:00:08 | 9 Aug 2021 | | | AEGIS-CKD study results published in AJKD | Shield Therapeutics PLC | RNS |
| 04/08/21 | | 16:41:17 | 4 Aug 2021 | | | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 04/08/21 | | 16:35:30 | 4 Aug 2021 | | | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 04/08/21 | | 14:05:49 | 4 Aug 2021 | | | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 04/08/21 | | 14:00:39 | 4 Aug 2021 | | | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 24/06/21 | | 07:00:03 | 24 Jun 2021 | | | US launch of Accrufer® confirmed for July 1, 2021 | Shield Therapeutics PLC | RNS |
| 23/06/21 | | 16:40:42 | 23 Jun 2021 | | | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
| 23/06/21 | | 16:35:29 | 23 Jun 2021 | | | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 21/06/21 | | 13:35:02 | 21 Jun 2021 | | | Investor presentation | Shield Therapeutics PLC | RNS |
| 18/06/21 | | 07:00:04 | 18 Jun 2021 | | | Directorate Change | Shield Therapeutics PLC | RNS |
| 17/06/21 | | 14:30:01 | 17 Jun 2021 | | | Results of 2021 Annual General Meeting | Shield Therapeutics PLC | RNS |
| 15/06/21 | | 18:15:01 | 15 Jun 2021 | | | Grant of share options to the CEO | Shield Therapeutics PLC | RNS |
| 28/05/21 | | 07:00:08 | 28 May 2021 | | | Appointment of new Chief Executive Officer | Shield Therapeutics PLC | RNS |
| 28/05/21 | | 07:00:07 | 28 May 2021 | | | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 21/05/21 | | 07:00:07 | 21 May 2021 | | | US update | Shield Therapeutics PLC | RNS |
| 18/05/21 | | 07:00:07 | 18 May 2021 | | | AEGIS-H2H study results published in IBD | Shield Therapeutics PLC | RNS |
| 17/05/21 | | 07:00:10 | 17 May 2021 | | | Commencement of trading on the OTCQX Best Market | Shield Therapeutics PLC | RNS |
